BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blondy S, Talbot H, Saada S, Christou N, Battu S, Pannequin J, Jauberteau MO, Lalloué F, Verdier M, Mathonnet M, Perraud A. Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer. J Cell Mol Med 2021;25:47-60. [PMID: 33325631 DOI: 10.1111/jcmm.15752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Currie J, Demeule M, Charfi C, Zgheib A, Larocque A, Danalache BA, Ouanouki A, Béliveau R, Marsolais C, Annabi B. The Peptide-Drug Conjugate TH1902: A New Sortilin Receptor-Mediated Cancer Therapeutic against Ovarian and Endometrial Cancers. Cancers 2022;14:1877. [DOI: 10.3390/cancers14081877] [Reference Citation Analysis]
2 Blondy S, Talbot H, Saada S, Christou N, Battu S, Pannequin J, Jauberteau MO, Lalloué F, Verdier M, Mathonnet M, Perraud A. Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer. J Cell Mol Med 2021;25:47-60. [PMID: 33325631 DOI: 10.1111/jcmm.15752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Berger K, Pauwels E, Parkinson G, Landberg G, Le T, Demillo VG, Lumangtad LA, Jones DE, Islam MA, Olsen R, Kapri T, Intasiri A, Vermeire K, Rhost S, Bell TW. Reduction of Progranulin-Induced Breast Cancer Stem Cell Propagation by Sortilin-Targeting Cyclotriazadisulfonamide (CADA) Compounds. J Med Chem 2021;64:12865-76. [PMID: 34428050 DOI: 10.1021/acs.jmedchem.1c00943] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gao Y, Li Y, Song Z, Jin Z, Li X, Yuan C, Yang D. Sortilin 1 Promotes Hepatocellular Carcinoma Cell Proliferation and Migration by Regulating Immune Cell Infiltration. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/6509028] [Reference Citation Analysis]